The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease.
about
Interactions among vascular-tone modulators contribute to high altitude pulmonary edema and augmented vasoreactivity in highlandersBiomarkers in asthma: a real hope to better manage asthma.Oxidized phospholipids reduce vascular leak and inflammation in rat model of acute lung injuryOxidized phospholipids reduce ventilator-induced vascular leak and inflammation in vivoQuantification of the oxidative damage biomarker 2,3-dinor-8-isoprostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry.Increased susceptibility to hyperoxic lung injury and alveolar simplification in newborn rats by prenatal administration of benzo[a]pyrene.Simultaneous HPLC-MS-MS quantification of 8-iso-PGF(2alpha) and 8,12-iso-iPF(2alpha) in CSF and brain tissue samples with on-line cleanupInducible nitric oxide synthase regulates production of isoprostanes in vivo during chlamydial genital infection in mice.Asthma, airway biology, and nasal disorders in AJRCCM 2002.Respiratory mechanics do not always mirror pulmonary histological changes in emphysema.Prenatal administration of the cytochrome P4501A inducer, Β-naphthoflavone (BNF), attenuates hyperoxic lung injury in newborn mice: implications for bronchopulmonary dysplasia (BPD) in premature infants.Application of gas chromatography-mass spectrometry for analysis of isoprostanes: their role in cardiovascular disease.Plasma biomarkers of oxidative stress and genetic variants in age-related macular degeneration.Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons: results from the health aging and body composition study.The short-term effects of antioxidant and zinc supplements on oxidative stress biomarker levels in plasma: a pilot investigation.Urinary biomarkers of oxidative status.Effects of chronic and acute ozone exposure on lipid peroxidation and antioxidant capacity in healthy young adults.Impact of ramadan intermittent fasting on oxidative stress measured by urinary 15-f(2t)-isoprostaneReactive oxygen species and erectile dysfunction: possible role of NADPH oxidase.Association between adherens junctions and tight junctions via Rap1 promotes barrier protective effects of oxidized phospholipids.Cross talk between paxillin and Rac is critical for mediation of barrier-protective effects by oxidized phospholipids.Clinical use of exhaled biomarkers in COPD.Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives.Molecular signatures of obstructive sleep apnea in adults: a review and perspective.NAD(P)H quinone oxidoreductase 1 is essential for ozone-induced oxidative stress in mice and humans.NADPH oxidases and reactive oxygen species at different stages of chronic hypoxia-induced pulmonary hypertension in newborn piglets.Isoprostanes and asthma.Barrier enhancing signals in pulmonary edema.Correlation between two markers of inflammation, serum C-reactive protein and interleukin 6, and indices of oxidative stress in patients with high risk of cardiovascular disease.Perioperative plasma F(2)-Isoprostane levels correlate with markers of impaired ventilation in infants with single-ventricle physiology undergoing stage 2 surgical palliation on the cardiopulmonary bypass.A randomized clinical trial of ascorbic acid in open abdominal aortic aneurysm repair.Role of IQGAP1 in endothelial barrier enhancement caused by OxPAPC.Sustained elevation of systemic oxidative stress and inflammation in exacerbation and remission of asthmaIloprost inhibits superoxide formation and gp91phox expression induced by the thromboxane A2 analogue U46619, 8-isoprostane F2alpha, prostaglandin F2alpha, cytokines and endotoxin in the pig pulmonary artery.BAL fluid 8-isoprostane concentrations in eosinophilic bronchitis and asthma.Induced sputum 8-isoprostane concentrations in inflammatory airway diseases.Lipid peroxidation and 5-lipoxygenase activity in chronic obstructive pulmonary disease.Attenuation of hyperoxic lung injury by the CYP1A inducer beta-naphthoflavone.Inhaled fluticasone reduces bronchial responsiveness and airway inflammation in cats with mild chronic bronchitis.Urinary F2-isoprostanes are not associated with increased risk of type 2 diabetes.
P2860
Q28483668-2C97DC05-8317-495A-8630-6877C9EBC1D3Q30417360-2970ED8D-ED52-4438-806A-C4B41D1F9E99Q30439914-9EDC529E-B410-47B4-A4C8-E6C67B03C1F1Q30441814-D5C0D8F9-C627-4FFF-B61E-E5C9269AD675Q33783345-1B7F7350-4407-4376-9DAD-0B7F4700548EQ34214534-1DD2E00C-02F2-4149-92B3-ECB70FE075D4Q34284645-9E0EB5F1-56AE-4BC1-9416-8E5EB5BDBA59Q34946110-5648F1F8-D0E6-4C90-94D1-BD20B6163FF8Q35055447-1315F553-2E59-4E19-B5B0-F20C7EEE3844Q35232410-0CDBCF69-46D0-464E-AF3C-8EA5458D76E7Q35381595-1003183C-CCD7-4144-9FF6-779DA154B7DBQ35621906-72CC33D5-8F69-4A8F-AC4F-F6642BB255BDQ35784919-78333E57-B443-4FAB-8128-57B774EB52D4Q35947427-27DE77BA-B517-46DD-8E2E-DA1C9289E8EAQ35981098-F9BB8012-37A0-4BA0-B9A0-EB42921A7BC6Q36178739-C6FC1F6E-A9F3-4D74-B76E-C022787D5BD4Q36264515-3ED0D7C1-6F47-4FC3-AE19-324AD26D7CDEQ36361108-FC9BA2F4-A00C-4C31-B018-711AD0B27BE0Q36629849-FA6E7DF6-88CA-4145-87FE-A852655FEDF0Q36840432-BE80F1C7-CBAD-4869-9D51-594739615870Q36956209-838EA482-A77D-4495-AF43-CE6A5D2C9742Q37082558-F89366F8-2793-4C98-84BE-5B6311351A7AQ37115894-D8D8B582-9623-4DC3-A28B-355ACF683644Q37146506-474E7A00-AA8B-46B0-888E-54833E1790A0Q37241608-E3849397-53B2-4DF0-AAF3-E8037C76B2BDQ37406398-AA3A3DD6-D27B-421C-8079-F9D618F3E665Q37877309-F39B4E0F-335A-469F-8930-EBAF0DEACC2CQ38110515-CE4C5C26-2DB3-4805-8734-AC9B72A329CEQ40174724-AEA387ED-D01B-4B12-AC24-3B420A33BEA0Q40306501-7865BD8C-73D8-40F5-AA6B-3DA529B8B73CQ41566858-E05CBDF5-E979-4DE5-AAC8-896556418574Q41630701-6C854435-FED7-4E00-9D90-0183367F69DFQ41898523-D4A706D1-F7B2-4191-999F-C6F164A1D681Q43263111-393D90B3-F54B-4878-A266-9ABE25BB4D66Q43281493-7D3AA06A-698B-41C3-B55E-41867559579CQ45173567-AB92E483-CFF3-4BCC-9007-607AD9522CEAQ45173571-6FBEF7EC-384B-421C-8297-681B1219F398Q46549147-D950CD1F-B468-41E5-A42E-F6D04DD2A753Q46743117-F284838E-DB91-4426-A68C-4309BE16F48EQ46750273-38036095-20AB-43F6-BE85-5D1142BBDDF2
P2860
The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The isoprostanes: their role a ...... us in human pulmonary disease.
@ast
The isoprostanes: their role a ...... us in human pulmonary disease.
@en
type
label
The isoprostanes: their role a ...... us in human pulmonary disease.
@ast
The isoprostanes: their role a ...... us in human pulmonary disease.
@en
prefLabel
The isoprostanes: their role a ...... us in human pulmonary disease.
@ast
The isoprostanes: their role a ...... us in human pulmonary disease.
@en
P2860
P356
P1476
The isoprostanes: their role a ...... us in human pulmonary disease.
@en
P2093
Jason D Morrow
L Jackson Roberts
P2860
P304
P356
10.1164/RCCM.2206011
P407
P433
P577
2002-12-01T00:00:00Z